Search clinical trials for: Niraparib
Total 221 results
-
Tesaro, Inc.Completed
-
Tesaro, Inc.Completed
-
Fudan UniversityCompletedTreatment EfficacyChina
-
Virginia Commonwealth UniversityGlaxoSmithKline; Puma Biotechnology, Inc.RecruitingOvarian Cancer | Advanced Solid TumorUnited States
-
Chongqing University Cancer HospitalRecruiting
-
Sun Yat-sen UniversityRecruitingNasopharyngeal CarcinomaChina
-
Institut Paoli-CalmettesGlaxoSmithKlineNot yet recruiting
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
Hunan Cancer HospitalUnknown
-
University of PennsylvaniaBristol-Myers Squibb; GlaxoSmithKlineCompletedPancreatic AdenocarcinomaUnited States
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Fundacion CRIS de Investigación para Vencer el...GlaxoSmithKline; Apices Soluciones S.L.; IpsenCompleted
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
MedSIRRecruitingOvarian Cancer | Oligometastatic Disease | Serous Ovarian TumorSpain
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
Pomeranian Medical University SzczecinRecruiting
-
David Liebner, MDWithdrawnLocally Advanced Leiomyosarcoma | Metastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Stage III Retroperitoneal Sarcoma AJCC v8 | Stage IIIA Retroperitoneal Sarcoma AJCC v8 | Stage IIIB Retroperitoneal Sarcoma AJCC v8 | Stage IV Retroperitoneal Sarcoma AJCC v8United States
-
University of Kansas Medical CenterTesaro, Inc.Active, not recruitingPancreatic CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
Tesaro, Inc.Merck Sharp & Dohme LLCCompletedNeoplasms | Breast Cancer | Advanced Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Peritoneal Cancer | Stage IV Breast CancerUnited States
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingRecurrent Glioma | Low-grade Glioma | Glioma, Malignant | IDH2 Gene Mutation | IDH1 MutationUnited States
-
University of Turin, ItalyRecruiting
-
Sir Mortimer B. Davis - Jewish General HospitalWithdrawnEndometrial Cancer | Uterine Neoplasm | Serous Adenocarcinoma
-
Tesaro, Inc.European Organisation for Research and Treatment of Cancer - EORTC; Breast... and other collaboratorsTerminatedOvarian Neoplasms | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Neoplasms, Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Carcinoma of BreastUnited States, Spain, Belgium, Israel, United Kingdom, Italy, Poland, Canada, Hungary, Netherlands, France, Portugal, Greece, Iceland
-
Hospices Civils de LyonRecruitingAdult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian CancerFrance
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid Tumor, AdultUnited States
-
University Hospital Southampton NHS Foundation...British Lung Foundation; University of SouthamptonActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
ARCAGY/ GINECO GROUPTesaro, Inc.Active, not recruitingOvarian Carcinosarcoma | Endometrial CarcinosarcomaFrance
-
Marc Dall'Era, MDNational Cancer Institute (NCI); Janssen, LPRecruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Prostate Carcinoma | RAD51C Gene Mutation | BRIP1 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CDK12 Gene Mutation | CHEK1 Gene Mutation | DNA Damage Response Gene Mutation | DNA Repair Gene Mutation | FANCA Gene Mutation and other conditionsUnited States
-
OHSU Knight Cancer InstituteEli Lilly and Company; GlaxoSmithKline; Oregon Health and Science UniversityActive, not recruitingInvasive Breast Carcinoma | Hormone Receptor Positive Breast Adenocarcinoma | Multifocal Breast Carcinoma | HER2 Negative Breast Adenocarcinoma | Unilateral Breast Carcinoma | Anatomic Stage II Breast Cancer AJCC V8 | Anatomic Stage I Breast Cancer AJCC V8 | Anatomic Stage IA Breast Cancer AJCC V8 | Anatomic Stage IB Breast Cancer AJCC V8 and other conditionsUnited States
-
Yale UniversityNational Institute on Aging (NIA); National Center for Research Resources (NCRR)CompletedBacteriuriaUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingOvarian Cancer RecurrentUnited Kingdom
-
Michelle S LudwigGlaxoSmithKlineTerminatedMetastatic Carcinoma of the CervixUnited States
-
Saint Elizabeth Regional Medical CenterWithdrawn
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT)Active, not recruitingOvarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal CarcinomaUnited States, Spain, Finland, Italy, Poland, Belgium, Denmark, Netherlands, France, Germany, Romania, Ukraine, Czechia, Norway, United Kingdom, Israel, Greece, Belarus, Canada
-
Byondis B.V.CompletedSolid TumorUnited Kingdom, Belgium, Netherlands
-
Sun Yat-sen UniversityRecruitingRecurrent/ Advanced Stage Endometrial Cancer PatientsChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Zai Lab (Shanghai) Co., Ltd.Active, not recruitingPlatinum-sensitive Relapsed Ovarian CancerChina
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
Sarcoma Alliance for Research through CollaborationCompleted
-
Zai Lab (Shanghai) Co., Ltd.TerminatedExtensive-stage Small Cell Lung CancerChina
-
Zai Lab (Shanghai) Co., Ltd.Active, not recruiting
-
University Hospital, CaenCompleted
-
Yonsei UniversityTakedaRecruitingPlatinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorKorea, Republic of
-
University Hospital, CaenCompleted
-
Tesaro, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingNeoplasmsUnited States, Netherlands, Spain, Finland, Germany, Israel, Belgium, Denmark, Sweden, United Kingdom, Poland, Canada, Hungary, Norway, Czechia, Italy, Ukraine, Belarus, Greece, Turkey
-
Avera McKennan Hospital & University Health CenterCompletedBreast Cancer | Ovarian CancerUnited States